isomethyleugenol has been researched along with Noonan Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Billia, F; Brown, KR; Burston, HE; Chen, S; Cowen, J; Coyaud, E; Dadson, K; De Carvalho, DD; He, HH; Ishak, C; Kannu, P; Kent, OA; Laurent, EM; Law, N; Matsumoto, Y; Montgomery-Song, A; Raught, B; Rose, J; Rottapel, R; Saha, M; St-Germain, J; Sun, RX | 1 |
1 other study(ies) available for isomethyleugenol and Noonan Syndrome
Article | Year |
---|---|
Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genes.
Topics: Abnormalities, Multiple; Animals; Chromosome Deletion; Chromosomes, Human, Pair 6; DNA-Binding Proteins; Epigenesis, Genetic; Female; Fibroblast Growth Factors; Haploinsufficiency; Histone Demethylases; Histones; Humans; Male; MAP Kinase Signaling System; Methylation; Mice, Inbred C57BL; Mice, Knockout; Noonan Syndrome; ras Proteins; Sin3 Histone Deacetylase and Corepressor Complex; Transcription Factors | 2020 |